Tenax Therapeutics (TENX) Other financing activities (2019 - 2026)
Tenax Therapeutics (TENX) posted quarterly Other financing activities of $30000.0 for Q1 2026, up 101.71% on a QoQ basis from -$1.8 million in Q4 2024.
Tenax Therapeutics (TENX) Other financing activities (2019 - 2026) Analysis & Trends
Tenax Therapeutics has reported Other financing activities for 7 years, with the latest figure at $30000.0 in Q1 2026.
- Other financing activities for Q1 2026 came in at $30000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2026 was $30000.0 (up 100.46% YoY), and the FY2025 annual result was $15.3 million, up 22397.06% from the prior year.
- Other financing activities improved to $30000.0 in Q1 2026, from -$1.8 million in the prior quarter.
- Over five years, Other financing activities peaked at $13.9 million in Q1 2023 and troughed at -$13.5 million in Q3 2023.
- A 4-year average of $10006.0 and a median of -$240155.5 in 2023 frame the typical range for Other financing activities.
- The largest YoY upside for Other financing activities was 93.56% in 2023 against a maximum downside of 269.68% in 2023.
- A 4-year view of Other financing activities shows it stood at -$7.9 million in 2022, then soared by 93.56% to -$510311.0 in 2023, then sank by 244.72% to -$1.8 million in 2024, then surged by 101.71% to $30000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $30000.0 in Q1 2026, -$1.8 million in Q4 2024, and -$4.7 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2024 | -1.76 Mn |
| Dec 31, 2024 | -1.76 Mn |
| Sep 30, 2024 | -4.70 Mn |
| Sep 30, 2024 | -4.70 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | -510,311.00 |
| Dec 31, 2023 | -510,311.00 |
| Mar 31, 2023 | 511,311.00 |
| Mar 31, 2023 | 511,311.00 |
| Dec 31, 2022 | -7.93 Mn |
| Dec 31, 2022 | -7.93 Mn |
| Sep 30, 2022 | 7.93 Mn |
| Sep 30, 2022 | 7.93 Mn |
| Dec 31, 2021 | 8.65 Mn |
| Dec 31, 2021 | 8.65 Mn |